Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.005
+0.005 (0.13%)
Mar 31, 2025, 10:59 AM EDT - Market open

Cytek Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
200.45193.02164.04127.9592.84
Upgrade
Revenue Growth (YoY)
3.85%17.67%28.20%37.82%60.39%
Upgrade
Cost of Revenue
89.3583.5963.0648.8141.13
Upgrade
Gross Profit
111.11109.43100.9779.1451.71
Upgrade
Selling, General & Admin
94.8393.1267.9245.5524.36
Upgrade
Research & Development
39.444.1534.8624.4413.69
Upgrade
Operating Expenses
134.23137.27102.7869.9938.05
Upgrade
Operating Income
-23.12-27.85-1.89.1613.66
Upgrade
Interest Expense
--2.07-2.57-1.74-0.33
Upgrade
Interest & Investment Income
10.366.414.620.050.11
Upgrade
Earnings From Equity Investments
--0.040.04-
Upgrade
Currency Exchange Gain (Loss)
4.467.790.98-1.570.99
Upgrade
EBT Excluding Unusual Items
-8.3-15.711.265.9414.43
Upgrade
Other Unusual Items
2.6----
Upgrade
Pretax Income
-5.7-15.711.265.9414.43
Upgrade
Income Tax Expense
0.32-3.56-1.222.91-4.98
Upgrade
Earnings From Continuing Operations
-6.02-12.152.483.0319.41
Upgrade
Minority Interest in Earnings
--0.090.03-
Upgrade
Net Income
-6.02-12.152.583.0519.41
Upgrade
Preferred Dividends & Other Adjustments
---316.2
Upgrade
Net Income to Common
-6.02-12.152.580.053.22
Upgrade
Net Income Growth
---15.62%-84.27%-
Upgrade
Shares Outstanding (Basic)
1311351357729
Upgrade
Shares Outstanding (Diluted)
1311351398233
Upgrade
Shares Change (YoY)
-3.45%-2.37%69.93%150.13%16.71%
Upgrade
EPS (Basic)
-0.05-0.090.020.000.11
Upgrade
EPS (Diluted)
-0.05-0.090.020.000.10
Upgrade
EPS Growth
--2906.28%-99.36%-
Upgrade
Free Cash Flow
21.850.63-21.980.2713.61
Upgrade
Free Cash Flow Per Share
0.170.01-0.160.000.42
Upgrade
Gross Margin
55.43%56.69%61.56%61.86%55.70%
Upgrade
Operating Margin
-11.54%-14.43%-1.10%7.16%14.71%
Upgrade
Profit Margin
-3.00%-6.29%1.57%0.04%3.46%
Upgrade
Free Cash Flow Margin
10.90%0.33%-13.40%0.21%14.66%
Upgrade
EBITDA
-15.91-21.80.6910.414.26
Upgrade
EBITDA Margin
-7.94%-11.29%0.42%8.13%15.36%
Upgrade
D&A For EBITDA
7.216.052.491.240.6
Upgrade
EBIT
-23.12-27.85-1.89.1613.66
Upgrade
EBIT Margin
-11.54%-14.43%-1.10%7.16%14.71%
Upgrade
Effective Tax Rate
---49.02%-
Upgrade
Revenue as Reported
200.45193.02164.04127.9592.84
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q